A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the normal stages of tissue repair within a predictable timeframe and include surgical wounds, burns, traumatic injuries, and lacerations. Chronic wounds fail to progress through the normal stages of healing promptly and may persist for months or years. Common examples include diabetic foot ulcers, pressure ulcers, venous leg ulcers, and arterial ulcers. The increasing prevalence of chronic diseases such as diabetes, obesity, cardiovascular disorders, and vascular insufficiencies is driving the incidence of diabetic foot ulcers, pressure ulcers, venous ulcers, and arterial ulcers.

The emerging innovations in advanced wound dressings and bioactive & regenerative wound care technologies focus on next-generation dressing materials designed to improve moisture balance, infection control, and wound healing outcomes. It also examines regenerative approaches, including skin substitutes, extracellular matrix products, growth factors, and tissue-engineered solutions that promote tissue repair and regeneration.

• What is the growth potential of advanced wound dressings and bioactive/regenerative technologies?
• How will improving healing outcomes, reducing complications, and addressing significant unmet clinical needs create substantial opportunities for innovation and growth.
• Which game-changing growth avenues will transform the wound management industry?